Targeted molecular therapy of head and neck squamous cell carcinoma with the tyrosine kinase inhibitor vandetanib in a mouse model.
about
HRAS mutations and resistance to the epidermal growth factor receptor tyrosine kinase inhibitor erlotinib in head and neck squamous cell carcinoma cells.Deguelin induces both apoptosis and autophagy in cultured head and neck squamous cell carcinoma cells.Overexpression of microRNA-30b improves adenovirus-mediated p53 cancer gene therapy for laryngeal carcinoma.Vandetanib restores head and neck squamous cell carcinoma cells' sensitivity to cisplatin and radiation in vivo and in vitro.Evolutionary Action Score of TP53 Identifies High-Risk Mutations Associated with Decreased Survival and Increased Distant Metastases in Head and Neck Cancer.Disruptive TP53 mutation is associated with aggressive disease characteristics in an orthotopic murine model of oral tongue cancer.Recent advances in biomarkers and potential targeted therapies in head and neck squamous cell carcinoma.GSK1059615 kills head and neck squamous cell carcinoma cells possibly via activating mitochondrial programmed necrosis pathway.
P2860
Q33568344-846FA517-52FD-4F5E-B5CD-8900E2A7EF81Q34571304-21104EF6-598F-4510-A845-83996E7FB18CQ34685049-D4B270D4-42A4-4ED5-8908-0F8464894483Q34781075-4189F2F6-DB9B-43A1-9CA1-067731C78B3BQ35251779-66171F01-D02D-407E-BF25-1527DDFC39FEQ35510945-854A6CFB-7216-49DB-8B71-13DA8E6D799CQ35825299-B5C36444-A19D-40A5-9828-8B5D35BA1DBDQ41612466-29131806-267B-4F28-9578-E7623928B514
P2860
Targeted molecular therapy of head and neck squamous cell carcinoma with the tyrosine kinase inhibitor vandetanib in a mouse model.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Targeted molecular therapy of ...... r vandetanib in a mouse model.
@ast
Targeted molecular therapy of ...... r vandetanib in a mouse model.
@en
Targeted molecular therapy of ...... r vandetanib in a mouse model.
@nl
type
label
Targeted molecular therapy of ...... r vandetanib in a mouse model.
@ast
Targeted molecular therapy of ...... r vandetanib in a mouse model.
@en
Targeted molecular therapy of ...... r vandetanib in a mouse model.
@nl
prefLabel
Targeted molecular therapy of ...... r vandetanib in a mouse model.
@ast
Targeted molecular therapy of ...... r vandetanib in a mouse model.
@en
Targeted molecular therapy of ...... r vandetanib in a mouse model.
@nl
P2093
P2860
P356
P1433
P1476
Targeted molecular therapy of ...... r vandetanib in a mouse model.
@en
P2093
Chad Galer
Daisuke Sano
David R Fooshee
Genevieve A Andrews
Jeffrey N Myers
Mitchell J Frederick
Phuong Khanh H Morrow
Zvonimir L Milas
P2860
P304
P356
10.1002/HED.21455
P577
2011-03-01T00:00:00Z